Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Shizuru

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
American Journal of Hematology|April 25, 2024
Management of post-autologous transplant relapse in patients with T-cell lymphomasOlivier Veilleux, Francisco Socola, Sally Arai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2007
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphomaAndrew R Rezvani, Barry Storer, Michael Maris, et al.
Science Translational Medicine|January 31, 2020
Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawalStephan Busque, John D Scandling, Robert Lowsky, et al.
Bone Marrow Transplantation|August 13, 2020
Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myelomaChristopher Lemieux, Lori S Muffly, Andrew Rezvani, et al.
Blood Advances|September 14, 2021
Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapyAndrew Johnsrud, Juliana Craig, John Baird, et al.
Transplantation and Cellular Therapy|May 18, 2022
Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern EraEmily C Liang, Juliana Craig, Stefan Torelli, et al.
British Journal of Haematology|September 2, 2008
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experienceAndrew R Rezvani, Lalitha Norasetthada, Ted Gooley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioningMohamed L Sorror, Barry E Storer, Brenda M Sandmaier, et al.
Bone Marrow Transplantation|September 5, 2019
Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experienceMazyar Shadman, David G Maloney, Barry Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2006
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group ReportKirk R Schultz, David B Miklos, Daniel Fowler, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
American Journal of Hematology|April 25, 2024
Management of post-autologous transplant relapse in patients with T-cell lymphomasOlivier Veilleux, Francisco Socola, Sally Arai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2007
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphomaAndrew R Rezvani, Barry Storer, Michael Maris, et al.
Science Translational Medicine|January 31, 2020
Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawalStephan Busque, John D Scandling, Robert Lowsky, et al.
Bone Marrow Transplantation|August 13, 2020
Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myelomaChristopher Lemieux, Lori S Muffly, Andrew Rezvani, et al.
Blood Advances|September 14, 2021
Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapyAndrew Johnsrud, Juliana Craig, John Baird, et al.
Transplantation and Cellular Therapy|May 18, 2022
Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern EraEmily C Liang, Juliana Craig, Stefan Torelli, et al.
British Journal of Haematology|September 2, 2008
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experienceAndrew R Rezvani, Lalitha Norasetthada, Ted Gooley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioningMohamed L Sorror, Barry E Storer, Brenda M Sandmaier, et al.
Bone Marrow Transplantation|September 5, 2019
Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experienceMazyar Shadman, David G Maloney, Barry Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2006
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group ReportKirk R Schultz, David B Miklos, Daniel Fowler, et al.
Pageof 3